Skip to main content

Table 3 Serum ferritin and TSAT responder analysis

From: Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data

      Number of    Percent with   
Outcome Comparator    Trials    Patients Ferric
carboxymaltose
   Control RB
95% CI
NNT
95% CI
Target ferritin increase All    3    611    61    43    1.6 (1.3 to 1.9)    5.6 (3.9 to 10)
  Oral iron    2    428    59    22    2.7 (2.0 to 3.6)    2.7 (2.2 to 3.6)
Target TSAT increase All    3    611    65    62    1.1 (0.9 to 1.2)    not calculated
  Oral iron    2    428    64    59    1.1 (0.9 to 1.3)    not calculated